UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES

Size: px
Start display at page:

Download "UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES"

Transcription

1 UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary Interchangeable Product(s) 6 Manufacturer Requested Discontinued Drug(s) 8 Drug Benefit Price(s) 9 New Manufacturer Name(s) 10 Not-A-Benefit Drug(s) 11 Discontinued Drug(s) (Removed From Payment & Listing) 12 Not-A-Benefit Drug(s) (Removed from Listing) 13 Status Change(s) from General Benefit to Limited Use 14 Trade Name Change(s) 15 Index 16 Page 1

2 New Single Source Drug(s) DIN PRODUCT GENERIC NAME MFR DBP Edurant 25mg Tab RILPIVIRINE HYDROCHLORIDE JAN Note: For use in combination with other antiretroviral therapies, for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment naive adult patients. Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism Viramune XR 400mg ER Tab NEVIRAPINE BOE Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism Visanne 2mg Tab DIENOGEST BAH Reason for Use Code 432 Clinical Criteria For the management of pelvic pain associated with endometriosis in patients for whom one or more less costly options are either ineffective or cannot be used. Note: For example for patients who are refractory to 6 months of continuous combined oral contraceptives and/or medroxyprogesterone therapy OR have contraindications to these therapies. LU Authorization Period: 1 Year Page 2

3 DIN PRODUCT GENERIC NAME MFR DBP Xarelto 15mg Tab RIVAROXABAN BAH Xarelto 20mg Tab RIVAROXABAN BAH Reason for Use Code 435 Clinical Criteria For the prevention of stroke and systemic embolism in at-risk patients who have non-valvular atrial fibrillation (AF) AND in whom: 1) Anticoagulation is inadequate following a reasonable trial on warfarin; OR 2) Anticoagulation with warfarin is contraindicated or not possible due to inability to regularly monitor via International Normalized Ratio (INR) testing (i.e., no access to INR testing services at a laboratory, clinic, pharmacy, and at home). Exclusion Criteria: Patients who: (a) have impaired renal function (creatinine clearance or estimated glomerular filtration rate less than 30mL/min); OR (b) are greater than or equal to 75 years in age without documented stable renal function; OR (c) have hemodynamically significant rheumatic valvular heart disease, especially mitral stenosis; OR (d) have prosthetic heart valves. Definitions and Clarification: (a) documented stable renal function is defined as creatinine clearance or estimated glomerular filtration rate that maintained for at least 3 months (i.e., 30-49mL/min for 15mg once daily dosing or greater than or equal to 50mL/min for 20mg once daily dosing for at least 3 months). (b) at-risk patients with atrial fibrillation are defined as those with a CHADS2 score of greater than or equal to 1. Although the ROCKET-AF trial included patients with higher CHADS2 score (greater than or equal to 2), other landmark studies with the other newer oral anticoagulants demonstrated a therapeutic benefit in patients with a CHADS2 score of 1. Prescribers may consider an antiplatelet regimen or oral anticoagulation for patients with a CHADS2 score of 1. Continued on the next page: Page 3

4 DIN PRODUCT GENERIC NAME MFR DBP Reason for Use Code Continued from the previous page Clinical Criteria Definitions and Clarification: (c) inadequate anticoagulation is defined as INR testing results that are outside of the desired INR range for at least 35% of the tests during the monitoring period (i.e., adequate anticoagulation is defined as INR test results that are within the desired INR range for at least 65% of the tests during the monitoring period). (d) a reasonable trial on warfarin is defined as at least 2 months of therapy. (e) Since renal impairment can increase bleeding risk, renal function should be regularly monitored. Other factors that increase bleeding risk should also be assessed and monitored (see Xarelto product monograph). (f) Patients starting rivaroxaban should have ready access to appropriate medical services to manage a major bleeding event. (g) There is currently no data to support that rivaroxaban provides adequate anticoagulation in patients with rheumatic valvular disease or those with prosthetic heart valves, so rivaroxaban is not recommended in these populations. LU Authorization Period: Indefinite Page 4

5 New Multi-Source Drug(s) DIN BRAND STRENGTH DOSAGE FORM MFR DBP Apo-Lamivudine 150mg Tab APX Apo-Lamivudine 300mg Tab APX (Interchangeable with 3TC) Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism. Reimbursement will not be provided for the treatment of hepatitis Apo-Lamivudine-Zidovudine 150mg & 300mg Tab APX (Interchangeable with Combivir) Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism Fluoxetine Capsules BP 20mg Cap ACH (Interchangeable with Prozac) Mar-Metformin 500mg Tab MAR (Interchangeable with Glucophage) Ran-Alendronate 10mg Tab RAN Ran-Alendronate 70mg Tab RAN (Interchangeable with Fosamax) Teva-Lamivudine/Zidovudine 150mg & 300mg Tab TEV (Interchangeable with Combivir) Note: For the treatment of HIV/AIDS, the prescriber must be approved for the Facilitated Access mechanism. Page 5

6 Off Formulary Interchangeable Product(s) DIN BRAND STRENGTH DOSAGE FORM MFR UNIT COST Co Bosentan 62.5mg Tab COB Co Bosentan 125mg Tab COB (Interchangeable with Tracleer) Mylan-Bosentan 62.5mg Tab MYL Mylan-Bosentan 125mg Tab MYL (Interchangeable with Tracleer) Mylan-Zolmitriptan ODT 2.5mg Orally Disintegrating Tab (Interchangeable with Zomig Rapimelt) MYL PMS-Bosentan 62.5mg Tab PMS PMS-Bosentan 125mg Tab PMS (Interchangeable with Tracleer) Piperacillin/Tazobactam powder for Injection Piperacillin/Tazobactam powder for Injection Piperacillin/Tazobactam powder for Injection (Interchangeable with Tazocin) 2g & 250mg Inj Pd-Vial Pk TEV g & 375mg Inj Pd-Vial Pk TEV g & 500mg Inj Pd-Vial Pk TEV Ran-Pioglitazone 15mg Tab RAN Ran-Pioglitazone 30mg Tab RAN Ran-Pioglitazone 45mg Tab RAN (Interchangeable with Actos) Page 6

7 DIN BRAND STRENGTH DOSAGE FORM MFR UNIT COST Sandoz Atomoxetine 10mg Cap SDZ Sandoz Atomoxetine 18mg Cap SDZ Sandoz Atomoxetine 25mg Cap SDZ Sandoz Atomoxetine 40mg Cap SDZ Sandoz Atomoxetine 60mg Cap SDZ Sandoz Atomoxetine 80mg Cap SDZ Sandoz Atomoxetine 100mg Cap SDZ (Interchangeable with Strattera) Sandoz Bosentan 62.5mg Tab SDZ Sandoz Bosentan 125mg Tab SDZ (Interchangeable with Tracleer) Page 7

8 Manufacturer Requested Discontinued Drug(s) Please note that these discontinued products will remain on the formulary until the current stock is depleted. DIN BRAND STRENGTH DOSAGE FORM MFR Apo-Hydroxyurea 500mg Cap APX Gen-Timolol 0.25% Oph Sol GEN Lotensin 10mg Tab NOV M.O.S mg Tab VAL Mylan-Amilazide 5mg & 50mg Tab MYL Phenazo 200mg Tab VAL Tofranil 50mg Tab NOV Page 8

9 Drug Benefit Price(s) DIN BRAND STRENGTH DOSAGE FORM MFR DBP Aggrenox 200mg/25mg Cap BOE Atrovent HFA 20mcg/Metered Dose Inh-200 Dose Pk BOE Betaderm 0.05% Cr TAR Betaderm 0.1% Cr TAR Betaderm 0.05% Oint TAR Betaderm 0.1% Oint TAR Flomax CR Tab 0.4mg BOE Micardis 40mg Tab BOE Micardis 80mg Tab BOE Micardis Plus 80mg & 12.5mg Tab BOE Micardis Plus 80mg & 25mg Tab BOE Mirapex 0.25mg Tab BOE Mirapex 0.25mg Tab BOE Mirapex 1mg Tab BOE Mirapex 1mg Tab BOE Mirapex 1.5mg Tab BOE Mirapex 1.5mg Tab BOE PMS-Sodium 1% Inh Sol-2mL Pk PMS Cromoglycate Spiriva 18mcg Cap BOE Page 9

10 New Manufacturer Name(s) DIN BRAND STRENGTH DOSAGE FORM MFR Novo-Alendronate 5mg Tab TEV Novo-Alendronate 10mg Tab TEV Novo-Alprazol 0.25mg Tab TEV Novo-Alprazol 0.5mg Tab TEV Novo-Amiodarone 200mg Tab TEV Novo-Amlodipine 5mg Tab TEV Novo-Amlodipine 10mg Tab TEV Novo-Atenol 50mg Tab TEV Novo-Atenol 100mg Tab TEV Novo-Atenolthalidone 50 & 25mg Tab TEV Novo-Atenolthalidone 100 & 25mg Tab TEV Novo-Azathioprine 50mg Tab TEV Novo-Carbamaz 200mg Tab TEV Novo-Clindamycin 150mg Cap TEV Page 10

11 Not-A-Benefit Drug(s) DIN BRAND STRENGTH DOSAGE FORM MFR Capoten 50mg Tab BQU Zantac 15mg/mL Oral Sol GSK Page 11

12 Discontinued Drug(s) (Removed From Payment & Listing) DIN BRAND STRENGTH DOSAGE FORM MFR Apo-Naproxen SR 750mg SR Tab APX Benoxyl 5% Lot STI Benoxyl 20% Lot STI Fragmin 10000IU/0.4mL Inj Pref Syr PFI Fragmin 12500IU/0.5mL Inj Pref Syr PFI Fragmin 15000IU/0.6mL Inj Pref Syr PFI Fragmin 18000IU/0.72mL Inj Pref Syr PFI Gen-Bromazepam 1.5mg Tab GEN Gen-Bromazepam 3mg Tab GEN Gen-Bromazepam 6mg Tab GEN Gen-Buspirone 10mg Tab GEN Gen-Cyproterone 50mg Tab GEN Gen-Divalproex 125mg Tab GEN Gen-Divalproex 250mg Tab GEN Gen-Divalproex 500mg Tab GEN Gen-Naproxen EC 250mg Tab GEN Gen-Nizatidine 300mg Cap GEN Gen-Pindolol 5mg Tab GEN Gen-Pindolol 10mg Tab GEN Gen-Pindolol 15mg Tab GEN Gen-Salbutamol 5mg/mL Inh Sol-10mL Pk GEN Gen-Timolol 0.5% Oph Sol GEN Hepalean 50000USP U/5mL Inj Sol-5mL Pk ORG Hepalean 10000USP U/10mL Inj Sol-10mL Pk ORG Innohep 4500IU/0.45mL Inj Pref Syr LEO Innohep 14000IU/0.7mL Inj Pref Syr LEO Innohep 18000IU/0.9mL Inj Pref Syr LEO Lumigan 0.03% Oph Sol ALL Mylan-Fluconazole 150mg Cap MYL Novo-Purol 100mg Tab NOP Novo-Purol 200mg Tab NOP Novo-Purol 300mg Tab NOP PMS-Fluphenazine Decanoate 125mg/5mL Inj Susp-5mL Pk PMS PMS-Morphine Sulfate 15mg SR Tab PMS PMS-Morphine Sulfate 30mg SR Tab PMS PMS-Morphine Sulfate SR 100mg SR Tab PMS PMS-Morphine Sulfate SR 200mg SR Tab PMS PMS-Pamidronate 9mg/mL Inj Sol-10mL Vial PMS Pregestimil Pd-454g Pk MJN Sandoz Metoprolol (Type L) 50mg Tab SDZ Sandoz Metoprolol (Type L) 100mg Tab SDZ Stieva-A 0.03% Sol STI UltraMOP 10mg SG Cap CDX Page 12

13 Not-A-Benefit Drug(s) (Removed From Listing) DIN BRAND STRENGTH DOSAGE FORM MFR Modecate 125mg/5mL Inj Susp-5mL Pk BQU Naprosyn SR 750mg SR Tab HLR Page 13

14 Status Change(s) from General Benefit to Limited Use DIN BRAND STRENGTH DOSAGE FORM MFR DBP Xarelto 10mg Tab BAH Reason for Use Code 433 Clinical Criteria For the prevention of venous thromboembolic events in patients who have undergone elective total knee replacement (TKR) surgery. Note: Limited to 14 days of reimbursement in TKR. Limited to 1 claim in a 120 day period. LU Authorization Period: 1 Year 434 For the prevention of venous thromboembolic events in patients who have undergone elective total hip replacement (THR). Note: Limited to 35 days of reimbursement in THR. Limited to 1 claim in a 120 day period. LU Authorization Period: 1 Year Page 14

15 Trade Name Change(s) DIN BRAND STRENGTH DOSAGE FORM MFR Teva-Alendronate 5mg Tab NOP Teva-Alendronate 10mg Tab NOP Teva-Alprazolam 0.25mg Tab NOP Teva-Alprazolam 0.5mg Tab NOP Teva-Amiodarone 200mg Tab NOP Teva-Amlodipine 5mg Tab NOP Teva-Amlodipine 10mg Tab NOP Teva-Atenolol 50mg Tab NOP Teva-Atenolol 100mg Tab NOP Teva-Atenolol/Chlorthalidone 50 & 25mg Tab NOP Teva-Atenolol/Chlorthalidone 100 & 25mg Tab NOP Teva-Azathioprine 50mg Tab NOP Teva-Carbamazepine 200mg Tab NOP Teva-Clindamycin 150mg Cap NOP Page 15

16 CONSOLIDATED INDEX PRODUCT, STRENGTH & DOSAGE FORM DIN MFR UPDATE PAGE mg Tab PEN P 10 3TC 10mg/mL O/L GSK H VIH X 21 3TC 150mg Tab GSK H VIH X 21 3TC 300mg Tab GSK H VIH X 21 5-AMINOSALICYLIC ACID E 3 H 3 5-Benzagel 5% Gel NOV F 6 Abilify 2mg Tab BQU AB BQU AH 10 Abilify 5mg Tab BQU AB BQU AH 10 Abilify 10mg Tab BQU AB BQU AH 10 Abilify 15mg Tab BQU AB BQU AH 10 Abilify 20mg Tab BQU AB BQU AH 10 Abilify 30mg Tab BQU AB BQU AH 10 Accel Pioglitazone 15mg Tab ACC L 16 Accel Pioglitazone 30mg Tab ACC L 16 Accel Pioglitazone 45mg Tab ACC L 16 Accupril 5mg Tab PFI Q PFI Y PFI AG 10 Accupril 10mg Tab PFI Q PFI Y PFI AG 10 Accupril 20mg Tab PFI Q PFI Y PFI AG 10 Accupril 40mg Tab PFI Q PFI Y PFI AG 10 Accuretic 10mg & 12.5mg Tab PFI Q PFI Y PFI AG 10 Accuretic 20mg & 12.5mg Tab PFI Q PFI Y PFI AG 10 Accuretic 20mg & 25mg Tab PFI H PFI Q PFI Y 7 Page 16

17 ACEBUTOLOL Z 4 Acebutolol 100mg Tab SAI Z SAI AD 18 Acebutolol 200mg Tab SAI Z SAI AD 18 Acebutolol 400mg Tab SAI Z SAI AD 18 ACETAMINOPHEN AE 6 Acetaminophen Tab 325mg DPC AF DPC AH 12 Acetaminophen Extra Strength 500mg Tab DPC S DPC Z 26 Acetazolamide 250mg Tab APX X 28 AcetOxyl 5% Gel STI M STI U 12 AcetOxyl 10% Gel STI M STI U 12 ACETYLSALICYLIC ACID & BUTALBITAL & CAFFEINE E 8 ACETYLSALICYLIC ACID & BUTALBITAL & CAFFEINE & E 8 CODEINE PHOSPHATE Aclasta 5mg/100mL Inj Sol-100mL Pk NOV C NOV H 7 Actemra 80mg/4mL Inj Sol-Vial Pk HLR Y 7 Actemra 200mg/10mL Inj Sol-Vial Pk HLR Y 7 Actemra 400mg/20mL Inj Sol-Vial Pk HLR Y 7 Actonel 5mg Tab PGP A WAR AC WAR AG 10 Actonel 30mg Tab PGP A WAR AC WAR AG 10 Actonel 35mg Tab PGP A PGP R PGP W WAR AC 12 Actonel 150mg Tab PGP J PGP W WAR Y 9 Actonel DR 35mg DR Tab WAR AE 2 Actos 15mg Tab TAK L TAK X TAK AG 10 Actos 30mg Tab TAK L TAK X TAK AG 10 Actos 45mg Tab TAK L TAK X TAK AG 10 ACYCLOVIR Z 5 Page 17

18 Z 20 Acyclovir 200mg Tab SAI Z SAI AD 18 Acyclovir 400mg Tab SAI Z SAI AD 18 Acyclovir 800mg Tab SAI Z SAI AB SAI AD 18 Adalat PA 10 10mg LA Tab BAH X 25 Adalat PA 20 20mg LA Tab BAH X 25 Adalat XL 20mg ER Tab BAY F BAY O BAY AD 21 Adalat XL 30mg ER Tab BAY F BAY O BAY T 11 Adalat XL 60mg ER Tab BAY F BAY T 11 ADALIMUMAB I 2 Adderall XR 5mg ER Cap SHI H SHI Q SHI X SHI AD 21 Adderall XR 10mg ER Cap SHI H SHI Q SHI X SHI AD 21 Adderall XR 15mg ER Cap SHI H SHI Q SHI X SHI AD 21 Adderall XR 20mg ER Cap SHI H SHI Q SHI X SHI AD 21 Adderall XR 25mg ER Cap SHI H SHI Q SHI X SHI AD 21 Adderall XR 30mg ER Cap SHI H SHI Q SHI X SHI AD 21 Adrenalin 30mg/30mL Inj Sol-30mL Pk ERF C ERF F ERF P ERF X 10 Advagraf 0.5mg ER Cap ASE H 2 Advagraf 1mg ER Cap ASE H 2 Page 18

19 Advagraf 3mg ER Cap ASE W 2 Advagraf 5mg ER Cap ASE H 2 Advair /125mcg/Metered Dose Inh-120 Dose Pk GSK H 7 Advair /250mcg/Metered Dose Inh-120 Dose Pk GSK H 7 Advair Diskus 50/100mcg Inh-60 Dose Pk GSK H 7 Advair Diskus 50/250mcg Inh-60 Dose Pk GSK H 7 Advair Diskus 50/500mcg Inh-60 Dose Pk GSK H 7 Agenerase 50mg Cap GSK H GSK Q 23 Agenerase 150mg Cap GSK H GSK Q 23 Agenerase 15mg/mL O/L GSK H GSK Q 23 Aggrenox 200mg/25mg Cap BOE AJ 9 Airomir HFA 100mcg/Metered Dose Inh-200 dose Pk GRA U MMH U 16 Alcomicin 0.3% Oph Sol ALC M ALC U 12 Aldactazide-25 25mg & 25mg Tab PFI H PFI Q 14 Aldactazide-50 50mg & 50mg Tab PFI H PFI Q 14 Aldactone 25mg Tab PFI H PFI Q 14 Aldactone 100mg Tab PFI H PFI Q 14 ALENDRONATE N 2 Z 6 AI 2 AJ Alendronate 70mg Tab SAI Z SAI AD 18 Alendronate-FC 70mg Tab PHE V 15 ALENDRONATE & CHOLECALCIFEROL J 2 Alendronate Sodium Tablets 10mg Tab ACH AI 2 Alendronate Sodium Tablets 70mg Tab ACH AI 2 Alesse 20mcg & 100mcg Tab-21 Pk WAY H WAY Y WAY AG 10 Alesse 20mcg & 100mcg Tab-28 Pk WAY H WAY Y WAY AG 10 ALFUZOSIN HYDROCHLORIDE C 3 X 5 ALISKIREN D 3 Alkeran 2mg Tab GSK H TRT AE TRT AG 10 Allerdryl 25mg Cap VAL M 14 Page 19

20 Allerdryl 50mg Cap VAL N 9 Alomide 0.1% Oph Sol ALC X ALC AG 10 ALPRAZOLAM AB 5 Alprazolam 0.25mg Tab SAI AB SAI AD 18 Alprazolam 0.5mg Tab SAI AB SAI AD 18 Altace Cap 1.25mg SAV H SAV AG 10 Altace Cap 2.5mg SAV H SAV AG 10 Altace Cap 5mg SAV H SAV AG 10 Altace Cap 10mg SAV H SAV AG 10 Altace HCT 2.5mg & 12.5mg Tab SAV R SAV Z 24 Altace HCT 5mg & 12.5mg Tab SAV H SAV R SAV X 10 Altace HCT 5mg & 25mg Tab SAV H SAV R SAV X 10 Altace HCT 10mg & 12.5mg Tab SAV H SAV R SAV X SAV AG 10 Altace HCT 10mg & 25mg Tab SAV H SAV R SAV X SAV AG 10 Alvesco 100mcg/Actuation Inh-120 Dose Pk NYC H NYC Q NYC R NYC X NYC AG 10 Alvesco 200mcg/Actuation Inh-120 Dose Pk NYC H NYC Q NYC R NYC X NYC AG 10 Amatine 2.5mg Tab SHI Q SHI U SHI AE 16 Amatine 5mg Tab SHI Q SHI U SHI AE 16 Amiodarone 200mg Tab SAI AB 5 Page 20

21 SAI AD 18 AMIODARONE HCL R 5 AB 5 AMLODIPINE L 3 O 2 Q 5 S1 5 W 8 Z 6 AD 7 AE 6 AI 2 Amlodipine 5mg Tab SAI Z SAI AD 18 Amlodipine 10mg Tab SAI Z SAI AD 18 Amlodipine-Odan 5mg Tab ODN AI 2 Amlodipine-Odan 10mg Tab ODN AI 2 Amlodipine Tablets 5mg Tab RAN O RAN S 2 Amlodipine Tablets 10mg Tab RAN O RAN S 2 AMLODIPINE/ATORVASTATIN AB 6 AMOXICILLIN C 9 AB 7 Amoxicillin 250mg Chewable Tab SAI AB 7 Amoxicillin 250mg Chew Tab SAI AD 18 Amytal Sodium 60mg Cap LIL M LIL U 12 Amytal Sodium 200mg Cap LIL M LIL U 12 Anandron 50mg Tab SAV X SAV AG 10 Androderm 12.2mg Transdermal Patch PAL Q PAL X PAL AG 10 Androgel 1% 2.5g Foil Packet SPH A SPH AE 13 Androgel 1% 5.0g Foil Packet SPH AE 13 Ansaid 50mg Tab PFI Q 14 Ansaid 100mg Tab PFI Q 14 Anthraforte 1 1% Oint MEI F 6 Anthraforte 2 2% Oint MEI F 6 Anthranol 0.1% Cr MEI F 6 Anthranol 0.2% Cr MEI F 6 Anthranol 0.4% Cr MEI F 6 Anusol 0.5% Oint PFI M PFI U PFI W 16 Page 21

22 Anzemet 50mg Tab SAV H 7 Anzemet 100mg Tab SAV H SAV AG 10 Apidra 100U/mL Inj Sol-5x3mL Pk SAV K 2 Apidra 100U/mL Inj Sol-5x3mL SoloSTAR Pref Pen SAV W SAV X SAV AG 10 Apidra 100U/mL Inj Sol-10mL Vial SAV K SAV X SAV AG 10 Apidra 100U/mL Inj 5x3mL-Cart ClickStar Pen SAV R SAV AG 10 Apo-Acebutolol 100mg Tab APX S 2 Apo-Acebutolol 200mg Tab APX S 2 Apo-Acebutolol 400mg Tab APX S 2 Apo-Acetaminophen 325mg Tab APX Z 24 Apo-Acetaminophen 500mg Tab APX Z 24 Apo-Acetaminophen Caplets 325mg Caplet APX AE 6 Apo-Acetaminophen Caplets 500mg Capelt APX AE 6 Apo-Acetazolamide 250mg Tab APX H AAP X 21 Apo-Acyclovir 800mg Tab APX S APX AB 11 Apo-Alendronate 10mg Tab APX S 2 Apo-Alendronate 70mg Tab APX S 2 Apo-Alfuzosin 10mg Prolong-Rel Tab APX C APX D 9 Apo-Allopurinol 100mg Tab AAP AG 21 Apo-Allopurinol 200mg Tab AAP AG 21 Apo-Allopurinol 300mg Tab AAP AG 21 Apo-Alpraz 0.25mg Tab APX S 2 Apo-Alpraz 0.5mg Tab APX S 2 Apo-Amiloride 5mg Tab APX H 7 Apo-Amilzide 5mg & 50mg Tab APX S 2 Apo-Amiodarone 200mg Tab APX S 2 Apo-Amitriptyline 10mg Tab APX R AAP Y 9 Apo-Amitriptyline 25mg Tab APX R AAP Y 9 Apo-Amitriptyline 50mg Tab APX R AAP Y 9 Apo-Amlodipine 5mg Tab APX L APX S 2 Apo-Amlodipine 10mg Tab APX L APX S 2 Apo-Amoxi 250mg Cap APX V 13 Apo-Amoxi 500mg Cap APX V 13 Apo-Amoxi 25mg/mL O/L APX V 13 Apo-Amoxi 50mg/mL O/L APX V 13 Page 22

23 Apo-Amoxi Clav 250mg & 125mg Tab APX R 14 Apo-Amoxi Clav 875mg & 125mg Tab APX S 2 Apo-Atenidone 50 & 25mg Tab APX A 11 Apo-Atenidone 100 & 25mg Tab APX A 11 Apo-Atenol 50mg Tab APX S 2 Apo-Atenol 100mg Tab APX S 2 Apo-Atomoxetine 10mg Cap APX V 5 Apo-Atomoxetine 18mg Cap APX V 5 Apo-Atomoxetine 25mg Cap APX V 5 Apo-Atomoxetine 40mg Cap APX V 5 Apo-Atomoxetine 60mg Cap APX V 5 Apo-Atomoxetine 80mg Cap APX V 5 Apo-Atomoxetine 100mg Cap APX V 5 Apo-Atorvastatin 10mg Tab APX R1 2 Apo-Atorvastatin 20mg Tab APX R1 2 Apo-Atorvastatin 40mg Tab APX R1 2 Apo-Atorvastatin 80mg Tab APX R1 2 Apo-Azathioprine 50mg Tab APX S 2 Apo-Azithromycin 250mg Tab APX S 2 Apo-Baclofen 10mg Tab APX S 2 Apo-Baclofen 20mg Tab APX S 2 Apo-Benazepril 5mg Tab APX R AAP X 21 Apo-Benazepril 10mg Tab APX R AAP X 21 Apo-Benazepril 20mg Tab APX R AAP X 21 Apo-Bicalutamide 50mg Tab APX S 2 Apo-Bisoprolol 5mg Tab APX S 2 Apo-Bisoprolol 10mg Tab APX S 2 Apo-Brimonidine 0.2% Oph Sol APX S 2 Apo-Brimonidine P 0.15% Oph Sol APX B APX C APX M 15 Apo-Bromazepam 3mg Tab APX S 2 Apo-Bromazepam 6mg Tab APX S 2 Apo-Bromocriptine 2.5mg Tab APX AG 10 Apo-Bromocriptine 5mg Cap APX AG 10 Apo-C 100mg Tab APX X 25 Apo-C 250mg Tab APX X 25 Apo-C 1000mg Tab APX X 25 Apo-Cal 250 Eq to 250mg Elemental Calcium Tab APX AC 14 Apo-Cal 500 Eq to 500mg Elemental Calcium Tab APX AC 14 Apo-Calcitonin Nasal Spray 200IU Metered Dose Nas Sp-2x APX X 8 DosePk Apo-Candesartan 4mg Tab APX Z 6 Apo-Candesartan 8mg Tab APX Z 6 Apo-Candesartan 16mg Tab APX Z 6 Apo-Carbamazepine 200mg Tab APX Z 24 Page 23

24 Apo-Carbamazepine CR 200mg LA Tab APX M APX P 16 Apo-Carbamazepine CR 400mg LA Tab APX M APX P 16 Apo-Carvedilol 3.125mg Tab APX S 2 Apo-Carvedilol 6.25mg Tab APX S 2 Apo-Carvedilol 12.5mg Tab APX S 2 Apo-Carvedilol 25mg Tab APX S 2 Apo-Cefaclor 250mg Cap APX V APX AE 18 Apo-Cefaclor 500mg Cap APX V APX AE 18 Apo-Cefaclor 25mg/mL Oral Susp APX P APX X 24 Apo-Cefaclor 50mg/mL Oral Susp APX P APX X 24 Apo-Cefaclor 375mg/5mL Oral Susp APX I 7 Apo-Cefprozil 125mg/5mL Oral Susp-75mL Pk APX R APX R APX X 10 Apo-Cefprozil 125mg/5mL Oral Susp-100mL Pk APX R APX R APX R APX X 10 Apo-Cefprozil 250mg/5mL Oral Susp-75mL Pk APX R APX R APX X 10 Apo-Cefprozil 250mg/5mL Oral Susp-100mL Pk APX R APX R APX R APX X 10 Apo-Cefprozil 250mg Tab APX X 10 Apo-Cefprozil 500mg Tab APX X 10 Apo-Cetirizine 10mg Tab APX O 16 Apo-Chlordiazepoxide 5mg Cap APX H 7 Apo-Chlordiazepoxide 10mg Cap APX H 7 Apo-Chlordiazepoxide 25mg Cap APX H 7 Apo-Chlorthalidone 50mg Tab APX H AAP X 21 Apo-Chlorthalidone 100mg Tab APX S APX Z 26 Apo-Cilazapril 1mg Tab APX S 2 Apo-Cilazapril 2.5mg Tab APX S 2 Apo-Cilazapril 5mg Tab APX S 2 Apo-Cilazapril/HCTZ 5mg/12.5mg Tab APX H APX J 8 Apo-Cimetidine 200mg Tab APX Z 24 Apo-Cimetidine 600mg Tab APX S 2 Apo-Ciproflox 0.3% Oph Sol-5mL Pk APX R 10 Page 24

25 Apo-Ciproflox 250mg Tab APX S 2 Apo-Ciproflox 500mg Tab APX S 2 Apo-Ciproflox 750mg Tab APX S 2 Apo-Citalopram 20mg Tab APX S 2 Apo-Citalopram 40mg Tab APX S 2 Apo-Clarithromycin 250mg Tab APX S 2 Apo-Clindamycin 150mg Cap APX S 2 Apo-Clindamycin 300mg Cap APX S 2 Apo-Clobazam 10mg Tab APX S 2 Apo-Clonazepam 0.5mg Tab APX S 2 Apo-Clonazepam 2mg Tab APX S 3 Apo-Clopidogrel 75mg Tab APX AD 3 Apo-Clorazepate 3.75mg Cap APX R 14 Apo-Clorazepate 7.5mg Cap APX R 14 Apo-Clorazepate 15mg Cap APX R 14 Apo-Cloxi 250mg Cap APX V 13 Apo-Cloxi 500mg Cap APX V 13 Apo-Cloxi 25mg/mL O/L APX V 13 Apo-Cromolyn 1% Inh Sol-2mL Pk APX H 19 Apo-Cromolyn 2% Nas Sol-26mL Pk APX S APX Z 26 Apo-Cyclosporine Oral Solution 100mg/mL O/L APX F 3 Apo-Cyproterone 50mg Tab AAP X 21 Apo-Desipramine 25mg Tab APX R 14 Apo-Desipramine 50mg Tab APX Z 24 Apo-Desipramine 75mg Tab APX Z 24 Apo-Desmopressin 10mcg/Metered Dose Nas Sp-2.5mL Pk APX H AAP X 21 Apo-Desmopressin 0.1mg Tab APX S 3 Apo-Desmopressin 0.2mg Tab APX S 3 Apo-Dexamethasone 0.5mg Tab APX S 3 Apo-Dexamethasone 4mg Tab APX S 3 Apo-Diclo 25mg Ent Tab APX F APX S 3 Apo-Diclo 50mg Ent Tab APX S 3 Apo-Diclo SR 75mg LA Tab APX S APX U 9 Apo-Diclo SR 100mg LA Tab APX S APX U 9 Apo-Diflunisal 250mg Tab APX Z 24 Apo-Diflunisal 500mg Tab APX H 7 Apo-Digoxin mg Tab APX K APX M 13 Apo-Digoxin 0.125mg Tab APX N APX S APX S 32 Apo-Digoxin 0.25mg Tab APX N APX S APX S 32 Page 25

26 Apo-Diltiaz CD 120mg LA Cap APX S 3 Apo-Diltiaz CD 180mg LA Cap APX S 3 Apo-Diltiaz CD 240mg LA Cap APX S 3 Apo-Diltiaz CD 300mg LA Cap APX S 3 Apo-Diltiaz SR 60mg LA Cap APX H APX P APX S APX X 24 Apo-Diltiaz SR 90mg LA Cap APX H APX P APX S APX X 24 Apo-Diltiaz SR 120mg LA Cap APX H APX P APX S APX X 24 Apo-Diltiaz TZ 120mg SR Cap APX F APX S 3 Apo-Diltiaz TZ 180mg SR Cap APX F APX S 3 Apo-Diltiaz TZ 240mg SR Cap APX F APX S 3 Apo-Diltiaz TZ 300mg SR Cap APX F APX S 3 Apo-Diltiaz TZ 360mg SR Cap APX F APX S 3 Apo-Dipyridamole 25mg Tab APX G 7 Apo-Dipyridamole 50mg Tab APX G 7 Apo-Dipyridamole 75mg Tab APX G 7 Apo-Divalproex 125mg Ent Tab APX S 3 Apo-Divalproex 250mg Ent Tab APX S 3 Apo-Divalproex 500mg Ent Tab APX S 3 Apo-Domperidone 10mg Tab APX S 3 Apo-Dorzo-Timop 2% & 0.5% Oph Sol APX AC 5 Apo-Doxazosin 1mg Tab APX S 3 Apo-Doxazosin 2mg Tab APX S 3 Apo-Doxazosin 4mg Tab APX S 3 Apo-Doxepin 10mg Cap APX H 7 Apo-Doxy-Tabs 100mg Tab APX I 13 Apo-Enalapril 2.5mg Tab APX E APX V1 4 Apo-Enalapril 5mg Tab APX E APX V1 4 Apo-Enalapril 10mg Tab APX E APX V1 4 Apo-Enalapril 20mg Tab APX E APX V1 4 Apo-Enalapril Maleate/HCTZ 5mg & 12.5mg Tab APX X 8 Apo-Enalapril Maleate/HCTZ 10mg & 25mg Tab APX X 8 Page 26

27 Apo-Entacapone 200mg Tab APX AH 3 Apo-Erythro 250mg Tab APX H 7 Apo-Erythro-ES 600mg Tab APX H AAP X 21 Apo-Erythro-S 250mg Tab APX H AAP X 21 Apo-Erythro-S 500mg Tab APX H AAP X 21 Apo-Esomeprazole 20mg DR Tab APX W 9 Apo-Esomeprazole 40mg DR Tab APX W 9 Apo-Famciclovir 500mg Tab APX S 3 Apo-Famotidine 20mg Tab APX S 3 Apo-Famotidine 40mg Tab APX S 3 Apo-Feno-Micro 200mg Cap APX X 10 Apo-Feno-Super 100mg Tab APX D 10 Apo-Feno-Super 160mg Tab APX F APX S 3 Apo-Fenofibrate 100mg Cap APX J 8 Apo-Finasteride 5mg Tab APX AA 3 Apo-Flecainide 50mg Tab APX H AAP X 21 Apo-Flecainide 100mg Tab APX H AAP X 21 Apo-Floctafenine 200mg Tab APX H AAP X 21 Apo-Floctafenine 400mg Tab APX H AAP X 21 Apo-Fluconazole 50mg Tab APX S 3 Apo-Fluconazole 100mg Tab APX S 3 Apo-Fluconazole mg Cap APX S 3 Apo-Flunarizine 5mg Cap AAP X 21 Apo-Flunisolide 0.025% Nas Sp-25mL Pk APX J 8 Apo-Fluoxetine 20mg Cap APX S 3 Apo-Fluphenazine 1mg Tab APX H 8 Apo-Fluphenazine 2mg Tab APX H 8 Apo-Flurazepam 30mg Cap APX AG 10 Apo-Flurazepam 100mg Tab APX AG 10 Apo-Fluvoxamine 50mg Tab APX S 3 Apo-Fluvoxamine 100mg Tab APX S 3 Apo-Fosinopril 10mg Tab APX S 3 Apo-Fosinopril 20mg Tab APX S 3 Apo-Gabapentin 100mg Cap APX S APX U APX U 18 Apo-Gabapentin 300mg Cap APX S APX U APX U 18 Apo-Gabapentin 400mg Cap APX S APX U 17 Page 27

28 APX U 18 Apo-Gabapentin 600mg Tab APX A 14 Apo-Gabapentin 800mg Tab APX A 14 Apo-Gemfibrozil 300mg Cap APX S 3 Apo-Gliclazide 80mg Tab APX S 3 Apo-Gliclazide MR 30mg SR Tab APX A APX C AAP AG 21 Apo-Glyburide 2.5mg Tab APX S 3 Apo-Glyburide 5mg Tab APX S 3 Apo-Granisetron 1mg Tab APX I AAP X 21 Apo-Haloperidol 10mg Tab APX Z 24 Apo-Hydralazine 10mg Tab APX Z 24 Apo-Hydralazine 25mg Tab APX R 14 Apo-Hydralazine 50mg Tab APX Z 24 Apo-Hydro 12.5mg Tab APX Q 11 Apo-Hydro 25 25mg Tab APX S 3 Apo-Hydro 50 50mg Tab APX S 3 Apo-Hydromorphone 1mg Tab APX AI 2 Apo-Hydromorphone 2mg Tab APX AI 2 Apo-Hydromorphone 4mg Tab APX AI 2 Apo-Hydromorphone 8mg Tab APX AI 29 Apo-Hydroxyurea 500mg Cap APX AJ 8 Apo-Ibuprofen 200mg Tab APX Z 24 Apo-Ibuprofen 300mg Tab APX Z 24 Apo-Ibuprofen 400mg Tab APX Z 24 Apo-Ibuprofen 600mg Tab APX Z 24 Apo-Imipramine 10mg Tab APX H AAP X 21 Apo-Imipramine 25mg Tab APX H AAP X 21 Apo-Imipramine 50mg Tab APX H AAP X 21 Apo-Indapamide 1.25mg Tab APX S 3 Apo-Indapamide 2.5mg Tab APX S 3 Apo-Ipravent 0.03% Nasal Spray APX H APX Q 23 Apo-Ipravent 0.06% Nasal Spray APX J 10 Apo-Ipravent Inhalation Solution 250mcg/mL Inh Sol-20mL Pk APX S 3 Apo-ISDN 5mg SL Tab APX H AAP X 21 Apo-ISDN 10mg Tab APX H AAP X 21 Apo-ISDN 30mg Tab APX H AAP X 21 Apo-Keto 50mg Cap APX H AAP AH 11 Page 28

29 Apo-Keto-E 50mg Ent Tab APX J AAP AH 11 Apo-Keto-E 100mg Ent Tab APX H AAP AI 9 Apo-Keto SR 200mg LA Tab APX H AAP AG 21 Apo-Ketorolac 10mg Tab APX B 7 Apo-Labetalol 100mg Tab APX H APX L APX Q 23 Apo-Labetalol 200mg Tab APX H APX L APX Q 23 Apo-Lamivudine 150mg Tab APX AJ 5 Apo-Lamivudine 300mg Tab APX AJ 5 Apo-Lamivudine-Zidovudine 150mg & 300mg Tab APX AJ 5 Apo-Lamotrigine 25mg Tab APX S APX AB 11 Apo-Lamotrigine 100mg Tab APX S APX AB 11 Apo-Lamotrigine 150mg Tab APX S APX AB 11 Apo-Lansoprazole 15mg DR Cap APX K APX N APX S 4 Apo-Lansoprazole 30mg DR Cap APX K APX N APX S 4 Apo-Latanoprost 0.005% Oph Sol-2.5mL Pk APX AC 5 Apo-Leflunomide 10mg Tab APX S APX AA 11 Apo-Leflunomide 20mg Tab APX S APX AA 11 Apo-Letrozole 2.5mg Tab APX X 4 Apo-Levobunolol 0.5% Oph Sol APX S APX Z 26 Apo-Levocarb CR 100mg & 25mg Tab APX K AAP AG 21 Apo-Levocarb CR 200mg & 50mg Tab APX H APX S APX Z 26 Apo-Levofloxacin 250mg Tab APX L APX S 4 Apo-Levofloxacin 500mg Tab APX L APX S 4 Apo-Levofloxacin 750mg Tab APX L 16 Apo-Lisinopril 5mg Tab APX X APX X 10 Apo-Lisinopril 10mg Tab APX X 10 Page 29

30 APX X 10 Apo-Lisinopril 20mg Tab APX X APX X 10 Apo-Lisinopril/HCTZ 10 & 12.5mg Tab APX S 4 Apo-Lisinopril/HCTZ 20 & 12.5mg Tab APX S 4 Apo-Lisinopril/HCTZ 20 & 25mg Tab APX A 14 Apo-Lithium Carbonate SR 300mg ER Tab APX N 6 Apo-Loperamide 2mg Caplet APX S 4 Apo-Losartan 25mg Tab APX AF 2 Apo-Losartan 50mg Tab APX AF 2 Apo-Losartan 100mg Tab APX AF 2 Apo-Losartan/HCTZ 50mg & 12.5mg Tab APX AF 2 Apo-Losartan/HCTZ 100mg & 12.5mg Tab APX AF 2 Apo-Losartan/HCTZ 100mg & 25mg Tab APX AF 2 Apo-Lovastatin 20mg Tab APX S 4 Apo-Lovastatin 40mg Tab APX S 4 Apo-Loxapine 5mg Tab APX H APX Q 23 Apo-Loxapine 10mg Tab APX H APX Q 23 Apo-Loxapine 25mg Tab APX H APX Q 23 Apo-Loxapine 50mg Tab APX H APX Q 23 Apo-Medroxy 2.5mg Tab APX S 4 Apo-Medroxy 5mg Tab APX S 4 Apo-Medroxy 10mg Tab APX S 4 Apo-Medroxy 100mg Tab APX H APX AG 10 Apo-Mefenamic 250mg Cap APX R AAP AG 21 Apo-Mefloquine 250mg Tab AAP X 21 Apo-Megestrol 40mg Tab APX H AAP X 21 Apo-Megestrol 160mg Tab APX J AAP X 21 Apo-Meloxicam 7.5mg Tab APX S 4 Apo-Meloxicam 15mg Tab APX S 4 Apo-Memantine 10mg Tab APX AC 10 Apo-Metformin 500mg Tab APX S 4 Apo-Metformin ER 500mg ER Tab APX R 10 Apo-Methazolamide 50mg Tab APX H AAP X 21 Apo-Methoprazine 2mg Tab APX H 8 Apo-Methoprazine 5mg Tab APX AC 11 Apo-Methoprazine 25mg Tab APX AC 11 Apo-Methoprazine 50mg Tab APX AC 11 Apo-Methyldopa 125mg Tab APX H AAP X 21 Page 30

31 Apo-Methyldopa 250mg Tab APX H AAP X 21 Apo-Methyldopa 500mg Tab APX H AAP X 21 Apo-Methylphenidate 10mg Tab APX X 10 Apo-Methylphenidate ER 54mg SR Tab APX U 11 Apo-Methylphenidate SR 20mg ER Tab APX J 8 Apo-Metoprolol 50mg Tab APX S 4 Apo-Metoprolol 100mg Tab APX S 4 Apo-Metoprolol (Type L) 50mg Tab APX S 4 Apo-Metoprolol (Type L) 100mg Tab APX S 4 Apo-Metoprolol SR 100mg LA Tab APX C 7 Apo-Metoprolol SR 200mg LA Tab APX C 7 Apo-Metronidazole 250mg Tab APX H AAP X 21 Apo-Metronidazole 500mg Cap APX R AAP X 21 Apo-Midodrine 2.5mg Tab APX H AAP X 21 Apo-Midodrine 5mg Tab APX H AAP X 21 Apo-Mirtazapine 30mg Tab APX S 4 Apo-Misoprostol 100mcg Tab APX H AAP X 21 Apo-Misoprostol 200mcg Tab APX H AAP X 21 Apo-Moclobemide 150mg Tab APX S 4 Apo-Moclobemide 300mg Tab APX S 4 Apo-Montelukast 4mg Chew Tab APX AE 6 Apo-Montelukast 5mg Chew Tab APX AE 10 Apo-Montelukast 10mg Tab APX AD 16 Apo-Mycophenolate 250mg Cap APX AD 4 Apo-Mycophenolate 500mg Tab APX AD 4 Apo-Nadol 160mg Tab APX AC 11 Apo-Naproxen 125mg Tab APX H 8 Apo-Naproxen 500mg Tab APX Z 24 Apo-Naproxen SR 750mg SR Tab APX H APX Y APX AJ 12 Apo-Nifed 5mg Cap APX H AAP X 21 Apo-Nifed 10mg Cap APX J AAP X 21 Apo-Nifed PA 10mg LA Tab APX H APX P APX S APX X 24 Apo-Nifed PA 20mg LA Tab APX H APX P 8 Page 31

32 APX S APX X 24 Apo-Nitrazepam 5mg Tab APX X 10 Apo-Nitrazepam 10mg Tab APX X 10 Apo-Nitrofurantoin 50mg Tab APX H AAP X 21 Apo-Nitrofurantoin 100mg Tab APX H AAP X 21 Apo-Nizatidine 150mg Cap APX S 4 Apo-Nizatidine 300mg Cap APX S 4 Apo-Norflox 400mg Tab APX S 4 Apo-Nortriptyline 10mg Cap APX S 4 Apo-Nortriptyline 25mg Cap APX S 4 Apo-Oflox 200mg Tab AAP X 21 Apo-Oflox 300mg Tab AAP X 21 Apo-Oflox 400mg Tab AAP X 21 Apo-Ofloxacin 0.3% Oph Sol APX Z 24 Apo-Olanzapine 2.5mg Tab APX O APX P APX S 4 Apo-Olanzapine 5mg Tab APX O APX P APX S 4 Apo-Olanzapine 7.5mg Tab APX O APX P APX S 4 Apo-Olanzapine 10mg Tab APX O APX P APX S 4 Apo-Olanzapine 15mg Tab APX O APX P APX S 4 Apo-Olanzapine 20mg Tab APX O 19 Apo-Olanzapine ODT 5mg Rapid Dissolve Tab APX Y 3 Apo-Olanzapine ODT 10mg Rapid Dissolve Tab APX Y 3 Apo-Olanzapine ODT 15mg Rapid Dissolve Tab APX Y 3 Apo-Olanzapine ODT 20mg Rapid Dissolve Tab APX Y 5 Apo-Omeprazole 20mg Cap APX S 4 Apo-Omeprazole 20mg Cap APX S 4 Apo-Ondansetron 4mg/5mL O/L APX I AAP X 21 Apo-Ondansetron 4mg Tab APX S 4 Apo-Ondansetron 8mg Tab APX S 4 Apo-Orciprenaline 2mg/mL O/L APX R 14 Apo-Oxybutynin 5mg Tab APX S 4 Apo-Oxycodone/Acet 5mg & 325mg Tab APX L 3 Apo-Pantoprazole 40mg Ent Tab APX S 4 Apo-Paroxetine 20mg Tab APX S 4 Apo-Paroxetine 30mg Tab APX S 4 Page 32

33 Apo-Pen V-K 60mg/mL O/L APX V 13 Apo-Pen V-K 300mg Tab APX V 13 Apo-Pentoxifylline 400mg SR Tab APX Z 24 Apo-Perindopril 8mg Tab APX S APX AF 10 Apo-Perphenazine 2mg Tab APX H AAP X 22 Apo-Perphenazine 4mg Tab APX H AAP X 22 Apo-Perphenazine 8mg Tab APX H AAP X 22 Apo-Perphenazine 16mg Tab APX H AAP X 22 Apo-Pimozide 2mg Tab APX AC 11 Apo-Pindol 5mg Tab APX S 4 Apo-Pindol 10mg Tab APX S 4 Apo-Pindol 15mg Tab APX S 4 Apo-Piroxicam 10mg Cap APX S 4 Apo-Piroxicam 20mg Cap APX S 4 Apo-Pramipexole 0.25mg Tab APX S 4 Apo-Pramipexole 1mg Tab APX S 5 Apo-Pramipexole 1.5mg Tab APX S 5 Apo-Pravastatin 10mg Tab APX S 5 Apo-Pravastatin 20mg Tab APX S 5 Apo-Pravastatin 40mg Tab APX S 5 Apo-Prednisone 1mg Tab APX H 8 Apo-Prednisone 50mg Tab APX R APX AF 8 Apo-Primidone 125mg Tab APX H AAP X 22 Apo-Primidone 250mg Tab APX H AAP X 22 Apo-Prochlorazine 5mg Tab APX AC 11 Apo-Prochlorazine 10mg Tab APX AC 11 Apo-Propafenone 150mg Tab APX S 5 Apo-Propafenone 300mg Tab APX S 5 Apo-Propranolol 10mg Tab APX S 5 Apo-Propranolol 20mg Tab APX X 10 Apo-Propranolol 40mg Tab APX S 5 Apo-Propranolol 80mg Tab APX S 5 Apo-Propranolol 120mg Tab APX H 8 Apo-Quetiapine 25mg Tab APX D APX S 5 Apo-Quetiapine 100mg Tab APX D APX S 5 Apo-Quetiapine 200mg Tab APX D APX E APX S 5 Apo-Quetiapine 300mg Tab APX D 4 Page 33

34 APX E APX S 5 Apo-Rabeprazole 10mg Tab APX R APX S 5 Apo-Rabeprazole 20mg Tab APX R APX S 5 Apo-Raloxifene 60mg Tab APX I APX M 10 Apo-Ramipril 1.25mg Cap APX S 5 Apo-Ramipril 2.5mg Cap APX S 5 Apo-Ramipril 5mg Cap APX S 5 Apo-Ramipril 10mg Cap APX S 5 Apo-Ramipril 15mg Cap APX J 10 Apo-Ranitidine 150mg Tab APX S APX X 10 Apo-Ranitidine 300mg Tab APX S APX X 10 Apo-Repaglinide 0.5mg Tab APX AE 10 Apo-Repaglinide 1mg Tab APX AE 10 Apo-Repaglinide 2mg Tab APX AE 10 Apo-Risedronate 35mg Tab APX U 3 Apo-Risedronate 150mg Tab APX AI 2 Apo-Risperidone 1mg/mL O/L APX X 10 Apo-Risperidone 0.25mg Tab APX S 5 Apo-Risperidone 0.5mg Tab APX S 5 Apo-Risperidone 1mg Tab APX S 5 Apo-Risperidone 2mg Tab APX S 5 Apo-Risperidone 3mg Tab APX S 5 Apo-Risperidone 4mg Tab APX S 5 Apo-Rivastigmine 1.5mg Cap APX P APX S 5 Apo-Rivastigmine 3mg Cap APX P APX S 5 Apo-Rivastigmine 4.5mg Cap APX P APX S 5 Apo-Rivastigmine 6mg Cap APX P APX S 5 Apo-Ropinirole 0.25mg Tab APX Q APX S 5 Apo-Ropinirole 1mg Tab APX Q APX S 5 Apo-Ropinirole 2mg Tab APX Q APX S 5 Apo-Ropinirole 5mg Tab APX Q APX S 5 Apo-Rosuvastatin 5mg Tab APX AH 3 Apo-Rosuvastatin 10mg Tab APX AH 3 Apo-Rosuvastatin 20mg Tab APX AH 3 Apo-Rosuvastatin 40mg Tab APX AH 3 Page 34

35 Apo-Salvent 100mcg/Metered Dose Inh-200 dose Pk APX S 32 Apo-Salvent 2mg Tab APX H 8 Apo-Salvent 4mg Tab APX H 9 Apo-Salvent CFC Free 100mcg/Metered Dose Inh-200 dose Pk APX N 7 Apo-Salvent Ipravent Sterules 500mcg/2.5mg/2.5mL Inh Sol- 2.5mL Pk APX V APX A APX K 11 Apo-Salvent Sterule 1mg/mL Inh Sol-2.5mL Pk APX H 19 Apo-Salvent Sterule 2mg/mL Inh Sol-2.5mL Pk APX H 19 Apo-Sibutramine 10mg Cap APX P 15 Apo-Selegiline 5mg Tab APX S 5 Apo-Sertraline 25mg Cap APX S 5 Apo-Sertraline 50mg Cap APX S 5 Apo-Sertraline 100mg Cap APX S 5 Apo-Sibutramine 15mg Cap APX P 15 Apo-Simvastatin 5mg Tab APX S 5 Apo-Simvastatin 10mg Tab APX S 5 Apo-Simvastatin 20mg Tab APX S 5 Apo-Simvastatin 40mg Tab APX S 5 Apo-Simvastatin 80mg Tab APX S 5 Apo-Sucralfate 1g Tab APX S 5 Apo-Sulfinpyrazone 200mg Tab APX H AAP X 22 Apo-Tamsulosin CR Tab 0.4mg APX AC 6 Apo-Temazepam 15mg Cap APX S 5 Apo-Temazepam 30mg Cap APX S 5 Apo-Terazosin 1mg Tab APX S 6 Apo-Terazosin 2mg Tab APX S 6 Apo-Terazosin 5mg Tab APX S 6 Apo-Terazosin 10mg Tab APX S 5 Apo-Tetra 250mg Cap APX H AAP X 22 Apo-Ticlopidine 250mg Tab APX S 6 Apo-Timop 0.25% Oph Sol APX S 6 Apo-Timop 0.5% Oph Sol APX S 6 Apo-Timop Gel 0.5% Oph Gellan Sol APX W 3 Apo-Topiramate 25mg Tab APX S APX AB 11 Apo-Topiramate 100mg Tab APX S APX AB 11 Apo-Topiramate 200mg Tab APX S APX AB 11 Apo-Tramadol/Acet 37.5mg & 325mg Tab APX P 15 Apo-Trazodone 50mg Tab APX X 10 Apo-Trazodone 100mg Tab APX X 10 Apo-Trazodone D 150mg Tab APX X 10 Apo-Triazo 0.125mg Tab APX Z 24 Page 35

36 Apo-Triazo 0.25mg Tab APX Z 24 Apo-Trifluoperazine 1mg Tab APX H AAP X 22 Apo-Trifluoperazine 2mg Tab APX H AAP X 22 Apo-Trifluoperazine 5mg Tab APX H AAP X 22 Apo-Trifluoperazine 10mg Tab APX H AAP X 22 Apo-Trihex 2mg Tab APX H AAP X 22 Apo-Trihex 5mg Tab APX H AAP X 22 Apo-Trimebutine 100mg Tab AAP X 22 Apo-Trimebutine 200mg Tab AAP X 22 Apo-Trimethoprim 100mg Tab APX H AAP X 22 Apo-Trimethoprim 200mg Tab APX H AAP X 22 Apo-Trimip 75mg Cap APX H AAP AC 12 Apo-Trimip 12.5mg Tab APX H 9 Apo-Trimip 25mg Tab APX J 8 Apo-Trimip 50mg Tab APX J 8 Apo-Trimip 100mg Tab APX J 8 Apo-Valacyclovir 500mg Tab APX A APX S 6 Apo-Valacyclovir 1000mg Tab APX U 7 Apo-Valproic 250mg Cap APX S 6 Apo-Valproic 50mg/mL O/L APX S 6 Apo-Valsartan 40mg Tab APX AC 10 Apo-Valsartan 80mg Tab APX AC 6 Apo-Valsartan 160mg Tab APX AC 6 Apo-Valsartan 320mg Tab APX AC 6 Apo-Valsartan/HCTZ 80mg & 12.5mg Tab APX AH 3 Apo-Valsartan/HCTZ 160mg & 12.5mg Tab APX AH 3 Apo-Valsartan/HCTZ 160mg & 25mg Tab APX AH 3 Apo-Valsartan/HCTZ 320mg & 12.5mg Tab APX AH 3 Apo-Valsartan/HCTZ 320mg & 25mg Tab APX AH 3 Apo-Venlafaxine XR 37.5mg ER Cap APX Q APX S 6 Apo-Venlafaxine XR 75mg ER Cap APX Q APX S 6 Apo-Venlafaxine XR 150mg ER Cap APX Q APX S 6 Apo-Verap SR 240mg LA Tab APX S 6 Apo-Warfarin 1mg Tab APX X 11 Apo-Warfarin 2mg Tab APX X 11 Apo-Warfarin 2.5mg Tab APX X 11 Page 36

37 Apo-Warfarin 3mg Tab APX X 11 Apo-Warfarin 4mg Tab APX X 11 Apo-Warfarin 5mg Tab APX X 11 Apo-Warfarin 10mg Tab APX X 11 Apo-Zidovudine 100mg Cap APX J 10 Apo-Zolmitriptan 2.5mg Tab APX AH 7 Apri mg & 0.03mg Tab-21 Pk APX H APX AG 10 Apri mg & 0.03mg Tab-28 Pk APX H APX AG 10 Aranesp 150mcg/0.3mL Pref Syr-0.3mL Pk AMG Z 31 Aranesp 200mcg/0.4mL Pref Syr-0.4mL Pk AMG X AMG Z AMG AG 10 Aranesp 300mcg/0.6mL Pref Syr-0.6mL Pk AMG X AMG Z AMG AG 10 Aranesp 500mcg/1.0mL Pref Syr-1.0mL Pk AMG X AMG Z AMG AG 10 Arava 10mg Tab SAV X SAV AA SAV AG 10 Arava 20mg Tab SAV X SAV AA SAV AG 10 Aredia 3mg/mL Inj Sol-10mL Vial NOV C 10 Aredia 6mg/mL Inj Sol-10mL Vial NOV H 21 Aredia 9mg/mL Inj Sol-10mL Vial NOV C 10 Aricept 5mg Tab PFI Q 14 Aricept 10mg Tab PFI Q 14 Arimidex 1mg Tab AZC X 11 ARIPIPRAZOLE AB 2 Arixtra 2.5mg Inj-0.5mL Pk GSK H GSK AG 10 Aromasin 25mg Tab PFI Q PFI Y PFI AG 10 Artane 0.4mg/mL O/L LED A 16 Arthrotec 50 50mg & 200mcg Tab PFI Q PFI Y PFI AG 11 Arthrotec 75 75mg & 200mcg Tab PFI Q PFI Y PFI AG 11 Asacol 400mg Tab PGP M PGP W WAR X WAR AG 11 Page 37

38 Asacol 800mg Tab PGP M PGP W WAR X WAR AG 11 Ascensia Elite Strip BAL P 13 Atacand 4mg Tab AZC X AZC AG 11 Atacand 8mg Tab AZC X AZC AG 11 Atacand 16mg Tab AZC X AZC AG 11 Atacand 32mg Tab AZC I AZC X AZC AG 11 Atacand Plus 16mg & 12.5mg Tab AZC X AZC AG 11 Atacand Plus 32mg & 12.5mg Tab AZC S AZC X AZC AG 11 Atacand Plus 32mg & 25mg Tab AZC S AZC X AZC AG 11 ATOVAQUONE & PROGUANIL HCL AG 7 ATENOLOL R 5 AD 6 AF 3 ATOMOXETINE HCL V 5 W 9 AF 6 AI 6 AJ 7 Atrovastatin 10mg Tab SAI AC SAI AD 18 Atrovastatin 20mg Tab SAI AC SAI AD 18 Atrovastatin 40mg Tab SAI AC SAI AD 18 Atrovastatin 80mg Tab SAI AC SAI AD 18 ATORVASTATIN CALCIUM R1 2 S1 5 AC 6 AD 9 Atripla 600mg/300mg/200mg Tab BQU A BQU H BQU U BQU X BQU AG 11 Atropine Sulfate 1% Oph Oint-3.5g Pk ALC M 7 Page 38

Updates to the Alberta Human Services Drug Benefit Supplement

Updates to the Alberta Human Services Drug Benefit Supplement Updates to the Alberta Human Services Drug Benefit Supplement Effective January 1, 2016 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone

More information

Updates to the Alberta Drug Benefit List. Effective January 1, 2016

Updates to the Alberta Drug Benefit List. Effective January 1, 2016 Updates to the Alberta Drug Benefit List Effective January 1, 2016 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - September 2014 Effective September 25, 2014 Ministry of Health and Long-Term Care Table of Contents New Single Source

More information

NLPDP Coverage Status Table December 2015. Initial and maintenance fills are limited to a maximum 30 days

NLPDP Coverage Status Table December 2015. Initial and maintenance fills are limited to a maximum 30 days Coverage Table December 2015 02238646 282 MEP TABLET OPEN No 500 0.2103 02234510 282 TABLET OPEN No 500 0.0726 02238645 292 TABLET OPEN No 50 0.1877 02192691 3TC 10 MG/ML SOLUTION OPEN No 240 0.3454 02192683

More information

Updates to the Alberta Drug Benefit List. Effective March 1, 2015

Updates to the Alberta Drug Benefit List. Effective March 1, 2015 Updates to the Alberta Drug Benefit List Effective March 1, 2015 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

Antiplatelet and Antithrombotic Therapy. Dr Curry Grant Stroke Prevention Clinic Quinte Health Care

Antiplatelet and Antithrombotic Therapy. Dr Curry Grant Stroke Prevention Clinic Quinte Health Care Antiplatelet and Antithrombotic Therapy Dr Curry Grant Stroke Prevention Clinic Quinte Health Care Disclosure of Potential for Conflict of Interest Dr. F.C. Grant Atrial Fibrillation FINANCIAL DISCLOSURE:

More information

Three new/novel oral anticoagulants (NOAC) have been licensed in Ireland since 2008:

Three new/novel oral anticoagulants (NOAC) have been licensed in Ireland since 2008: Key Points to consider when prescribing NOACs Introduction Three new/novel oral anticoagulants (NOAC) have been licensed in Ireland since 2008: Dabigatran Etexilate (Pradaxa ) 75mg, 110mg, 150mg. Rivaroxaban

More information

The Role of the Newer Anticoagulants

The Role of the Newer Anticoagulants The Role of the Newer Anticoagulants WARFARIN = Coumadin DAGIBATRAN = Pradaxa RIVAROXABAN = Xarelto APIXABAN = Eliquis INDICATION DABIGATRAN (Pradaxa) RIVAROXABAN (Xarelto) APIXABAN (Eliquis) Stroke prevention

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION

STROKE PREVENTION IN ATRIAL FIBRILLATION STROKE PREVENTION IN ATRIAL FIBRILLATION OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention of ischemic stroke and arterial thromboembolism in patients

More information

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below Name: generic (trade) Rivaroxaban (Xarelto ) HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) RIVAROXABAN RECOMMENDED see specific recommendations for licensed indications below What it is Indications

More information

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013

Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Family physician with Rivergrove Medical Clinic Practice in the north end since 1985 Medical Director of the Wellness

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #326 (NQF 1525): Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS,

More information

Updates to the Alberta Human Services Drug Benefit Supplement

Updates to the Alberta Human Services Drug Benefit Supplement Updates to the Alberta Human Services Drug Benefit Supplement Effective December 1, 2014 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization MEDICAL ASSISTANCE HBOOK I. Requirements for Prior Authorization of Anticoagulants A. Prescriptions That Require Prior Authorization Prescriptions for Anticoagulants which meet any of the following conditions

More information

FDA Approved Oral Anticoagulants

FDA Approved Oral Anticoagulants FDA Approved Oral Anticoagulants Generic (Trade Name) Warfarin (Coumadin, Jantoven ) 1 FDA approved indication Prophylaxis and treatment of venous thromboembolism (VTE) Prophylaxis and treatment of thromboembolic

More information

Cardiology Update 2014

Cardiology Update 2014 Cardiology Update 2014 Update on the Novel Oral Anticoagulants (NOACS) Raymond Kawasaki, MD AMG Cardiology December 6, 2014 Disclosures I have no disclosures relevant to this presentation Contents I. The

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE June 22, 2015 SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Anticoagulants Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical

More information

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND: STROKE PREVENTION IN ATRIAL FIBRILLATION TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To guide clinicians in the selection of antithrombotic therapy for the secondary prevention

More information

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations

Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Dardo E. Ferrara MD Cardiac Electrophysiology North Cascade Cardiology PeaceHealth Medical Group Which anticoagulant

More information

Traditional anticoagulants

Traditional anticoagulants TEGH Family Practice Clinic Day April 4, 03 Use of Anticoagulants in 03: What s New (and What Isn t) Bill Geerts, MD, FRCPC Director, Thromboembolism Program, Sunnybrook HSC Professor of Medicine, University

More information

COMPARISON OF NEW ORAL ANTICOAGULANTS AND FREQUENTLY- ASKED QUESTIONS FROM PATIENTS. TARGET AUDIENCE: All Canadian health care professionals.

COMPARISON OF NEW ORAL ANTICOAGULANTS AND FREQUENTLY- ASKED QUESTIONS FROM PATIENTS. TARGET AUDIENCE: All Canadian health care professionals. COMPARISON OF NEW ORAL ANTICOAGULANTS AND FREQUENTLY- ASKED QUESTIONS FROM PATIENTS AND PHYSICIANS TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVES: To provide a comparison of the new

More information

Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto

Failure or significant adverse effects to all of the alternatives: Eliquis and Xarelto This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics

More information

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. A. Prescriptions That Require Prior Authorization MEDICAL ASSISTANCE HBOOK PRI AUTHIZATION OF PHARMACEUTICAL SERVICES I. Requirements for Prior Authorization of Anticoagulants A. Prescriptions That Require Prior Authorization Prescriptions for Anticoagulants

More information

Bridging the Gap: How to Transition from the NOACs to Warfarin

Bridging the Gap: How to Transition from the NOACs to Warfarin Bridging the Gap: How to Transition from the NOACs to April 24 th 2015 UAN: 0048-0000-15-034-L01-P Amanda Styer, Pharm.D. Marion General Hospital, OhioHealth Objectives: 1. Review labeling regarding transition

More information

Palliative Coverage Drug Benefit Supplement

Palliative Coverage Drug Benefit Supplement Palliative Coverage Drug Benefit Supplement Effective April 1, 2015 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

Newer Anticoagulants and Newer Diabetic Drug Classes. Nicole N. Nguyen, PharmD Senior Clinical Pharmacist Health Care Services August 21, 2013

Newer Anticoagulants and Newer Diabetic Drug Classes. Nicole N. Nguyen, PharmD Senior Clinical Pharmacist Health Care Services August 21, 2013 Newer Anticoagulants and Newer Diabetic Drug Classes Nicole N. Nguyen, PharmD Senior Clinical Pharmacist Health Care Services August 21, 2013 Apixaban Newer Anticoagulants Dabigatran etexilate Rivaroxaban

More information

NOAC Prescribing in Patients with Non-Valvular Atrial Fibrillation: Frequently Asked Questions

NOAC Prescribing in Patients with Non-Valvular Atrial Fibrillation: Frequently Asked Questions AC Prescribing in Patients with Non-Valvular Atrial Fibrillation: Frequently Asked Questions FAQ document jointly prepared by NHSGGC Haematology Service & Medicines Infmation On behalf of the Heart MCN

More information

Appendix C Factors to consider when choosing between anticoagulant options and FAQs

Appendix C Factors to consider when choosing between anticoagulant options and FAQs Appendix C Factors to consider when choosing between anticoagulant options and FAQs Choice of anticoagulant for non-valvular* atrial fibrillation: Clinical decision aid Patients should already be screened

More information

DVT/PE Management with Rivaroxaban (Xarelto)

DVT/PE Management with Rivaroxaban (Xarelto) DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular

More information

Bios 6648: Design & conduct of clinical research

Bios 6648: Design & conduct of clinical research Bios 6648: Design & conduct of clinical research Section 1 - Specifying the study setting and objectives 1. Specifying the study setting and objectives 1.0 Background Where will we end up?: (a) The treatment

More information

TA 256: Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation

TA 256: Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation Service Notification in response to DHSSPS endorsed NICE Technology Appraisals TA 256: Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation 1 Name of Commissioning

More information

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation Date of First Issue 06/06/2012 Approved 06/06/2012 Current Issue Date 29/10/2014 Review Date 29/10/2016 Version 1.4 EQIA Yes 01/06/2012

More information

Anticoagulant therapy

Anticoagulant therapy Anticoagulation: The risks Anticoagulant therapy 1990 2002: 600 incidents reported 120 resulted in death of patient 92 deaths related to warfarin usage 28 reports related to heparin usage Incidents in

More information

Anticoagulation at the end of life. Rhona Maclean Rhona.maclean@sth.nhs.uk

Anticoagulation at the end of life. Rhona Maclean Rhona.maclean@sth.nhs.uk Anticoagulation at the end of life Rhona Maclean Rhona.maclean@sth.nhs.uk Content Anticoagulant Therapies Indications for anticoagulation Venous thromboembolism (VTE) Atrial Fibrillation Mechnical Heart

More information

Novel OACs: How should we use them?"

Novel OACs: How should we use them? Novel OACs: How should we use them?" Iqwal Mangat, MD FRCPC" Director, Arrhythmia Service, St. Michaelʼs Hospital" Assistant Professor of Medicine, University of Toronto" Presenter Disclosure Dr. Iqwal

More information

DTC Update Volume 5 No 4 July 2015

DTC Update Volume 5 No 4 July 2015 DTC Update Volume 5 No 4 July 2015 A publication of the Provincial Drugs and Therapeutics Committee (DTC) for use within Alberta Health Services Provincial Drugs & Therapeutics Committee (DTC) In this

More information

Cardiovascular Subcommittee of PTAC Meeting held 27 February 2014. (minutes for web publishing)

Cardiovascular Subcommittee of PTAC Meeting held 27 February 2014. (minutes for web publishing) Cardiovascular Subcommittee of PTAC Meeting held 27 February 2014 (minutes for web publishing) Cardiovascular Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology

More information

Introduction. Background to this event. Raising awareness 09/11/2015

Introduction. Background to this event. Raising awareness 09/11/2015 Introduction Primary Care Medicines Governance HSCB Background to this event New class of medicines Availability of training Increasing volume of prescriptions Reports of medication incidents Raising awareness

More information

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.

Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach. Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight

More information

Cardiovascular Disease

Cardiovascular Disease Cardiovascular Disease 1 Cardiovascular Disease 1. More target specific oral anticoagulants (TSOAC) 2. Vorapaxar (Zonivity) 3. Continued noise about a polypill 4. WATCHMAN 3 1 2 3 4 Left Atrial Appendage

More information

TSOAC Initiation Checklist

TSOAC Initiation Checklist Task Establish appropriate dose based on anticoagulant selected, indication and patient factors such as renal function. Evaluate for medication interactions that may necessitate TSOAC dose adjustment.

More information

Hot Line Session at European Society of Cardiology (ESC) Congress 2014:

Hot Line Session at European Society of Cardiology (ESC) Congress 2014: Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Hot Line Session at European Society of Cardiology (ESC) Congress 2014: Once-Daily

More information

CDEC FINAL RECOMMENDATION

CDEC FINAL RECOMMENDATION CDEC FINAL RECOMMENDATION RIVAROXABAN (Xarelto Bayer Inc.) New Indication: Atrial Fibrillation, Stroke Prevention Recommendation: The Canadian Drug Expert Committee (CDEC) recommends that rivaroxaban be

More information

4/9/2015. Risk Stratify Our Patients. Stroke Risk in AF: CHADS2 Scoring system JAMA 2001; 285: 2864-71

4/9/2015. Risk Stratify Our Patients. Stroke Risk in AF: CHADS2 Scoring system JAMA 2001; 285: 2864-71 Anticoagulation in the 21 st Century Adam Karpman, D.O. Saint Francis Medical Center/Oklahoma State University Medical Center Disclosures: None Atrial Fibrillation Most common arrhythmia in clinical practice.

More information

The author has no disclosures

The author has no disclosures Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 Mary.bradbury@inova.org This presentation will discuss unlabeled and investigational use of products The author

More information

Indication: Indication: Protaxos is indicated in adults.

Indication: Indication: Protaxos is indicated in adults. Maklumat tambahan indikasi untuk upload pada laman web Year 2013 Products Approved For Additional Indication (DCA 262 28 Mac 2013) NO PRODUCT (ACTIVE INGREDIENT) 1. 1.1 EVISTA TABLET 60MG [ Raloxifene

More information

Anticoagulants in Atrial Fibrillation

Anticoagulants in Atrial Fibrillation Anticoagulants in Atrial Fibrillation Starting and Stopping Them Safely Carmine D Amico, D.O. Overview Learning objectives Introduction Basic concepts Treatment strategy & options Summary 1 Learning objectives

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic

More information

Prior Authorization Guideline

Prior Authorization Guideline Guideline Guideline Name Formulary Xarelto (rivaroxaban) UnitedHealthcare Community & State Approval Date 0/0/203 Revision Date 8//204 Technician Note: CPS Approval Date: /5/20; CPS Revision Date: 8/20/204

More information

Rivaroxaban shared care guidelines for the prevention of stroke and embolism in adult patients with nonvalvular atrial fibrillation.

Rivaroxaban shared care guidelines for the prevention of stroke and embolism in adult patients with nonvalvular atrial fibrillation. South West Essex Rivaroxaban Shared Care Guideline (SCG) Rivaroxaban shared care guidelines for the prevention of stroke and embolism in adult patients with nonvalvular atrial fibrillation. Introduction

More information

Dabigatran (Pradaxa) Guidelines

Dabigatran (Pradaxa) Guidelines Dabigatran (Pradaxa) Guidelines Dabigatran is a new anticoagulant for reducing the risk of stroke in patients with atrial fibrillation. Dabigatran is a direct thrombin inhibitor, similar to warfarin, without

More information

New Oral Anticoagulants. How safe are they outside the trials?

New Oral Anticoagulants. How safe are they outside the trials? New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants

More information

VOLUME No: 21 04 written by Sara Wilds & Kathryn Buchanan. Date of issue: June 2012 (updated November 2012 following NICE TA 256)

VOLUME No: 21 04 written by Sara Wilds & Kathryn Buchanan. Date of issue: June 2012 (updated November 2012 following NICE TA 256) Prescribing Points A NEWSLETTER FOR ALL HEALTH CARE PROFESSIONALS IN OXFORDSHIRE, WRITTEN BY THE MEDICINES MANAGEMENT TEAM, OXFORDSHIRE PCT, JUBILEE HOUSE, OXFORD BUSINESS PARK SOUTH, OXFORD, OX4 2LH.

More information

Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial

Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial Camillo Autore Università di Roma Sapienza II Facoltà di Medicina e Chirurgia

More information

PHARMACOLOGY UPDATE: BOOMER DRUGS

PHARMACOLOGY UPDATE: BOOMER DRUGS PHARMACOLOGY UPDATE: BOOMER DRUGS Sandra Brownstein, PharmD Evercare Clinical Pharmacy Director West Region Objectives: Review the new drugs that have recently been approved by the FDA Determine the role

More information

2/17/2015 ANTICOAGULATION UPDATE OBJECTIVES BRIEF REVIEW: CLASSES OF ORAL ANTICOAGULANTS

2/17/2015 ANTICOAGULATION UPDATE OBJECTIVES BRIEF REVIEW: CLASSES OF ORAL ANTICOAGULANTS ANTICOAGULATION UPDATE C AR R I E P AL M E R, D N P, RN, AN P - BC OBJECTIVES At the end of the presentation, the NP will be able to: Identify new indications for target-specific oral anticoagulants (TSOACs),

More information

Antiplatelet and Antithrombotics From clinical trials to guidelines

Antiplatelet and Antithrombotics From clinical trials to guidelines Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories

More information

Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation

Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation Drew Baldwin, MD Virginia Mason Seattle, Washington NCVH May 29,

More information

The Anti coagulated Patient: The Cardiologist s View. February 28, 2015

The Anti coagulated Patient: The Cardiologist s View. February 28, 2015 The Anti coagulated Patient: The Cardiologist s View February 28, 2015 Conflicts Dr. McMurtry has no conflicts to disclose. CanMeds Medical Expert (as Medical Experts, physicians integrate all of the CanMEDS

More information

Anticoagulants for stroke prevention in atrial fibrillation Patient frequently asked questions

Anticoagulants for stroke prevention in atrial fibrillation Patient frequently asked questions Anticoagulants for stroke prevention in atrial fibrillation Patient frequently asked questions What is atrial fibrillation?...2 What are dabigatran, rivaroxaban and apixaban and what are they used for?...2

More information

Home Delivery Prescription Program Drug List

Home Delivery Prescription Program Drug List Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think

More information

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary July 1, 2013 Bulletin #141 Drug Plan and Extended Benefits Branch ISSN 1923-0761 SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary Product DIN Pre-Markup ($) New

More information

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary November 1, 2014 Bulletin #150 ISSN 1923-0761 SASKATCHEWAN FORMULARY BULLETIN Update to the 62nd Edition of the Saskatchewan Formulary New Exception Drug Status (EDS) Listings Effective November 1, 2014

More information

RR 0.88 (95% CI: 0.77 1.00) P=0.051 (superiority) 3.75

RR 0.88 (95% CI: 0.77 1.00) P=0.051 (superiority) 3.75 ALL-CAUSE MORTALITY RR 0.88 (95% CI: 0.77 1.00) P=0.051 (superiority) Rate per year (%) 5.0 4.0 3.0 2.0 1.0 0 3.64 D150 mg BID 3.75 D110 mg BID RR 0.91 (95% CI: 0.80 1.03) P=0.13 (superiority) 4.13 Warfarin

More information

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation

NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation NHS FORTH VALLEY Rivaroxaban for Stroke Prevention in Atrial Fibrillation Date of First Issue 06/06/2012 Approved 06/06/2012 Current Issue Date 06/06/2012 Review Date 06/06/2014 Version 1.1 EQIA Yes /

More information

Birmingham, Sandwell and Solihull Cardiac and Stroke Network. Rivaroxaban or warfarin for treatment of Atrial Fibrillation: Position statement

Birmingham, Sandwell and Solihull Cardiac and Stroke Network. Rivaroxaban or warfarin for treatment of Atrial Fibrillation: Position statement Birmingham, Sandwell and Solihull Cardiac and Stroke Network Rivaroxaban or warfarin for treatment of Atrial Fibrillation: Position statement Introduction This guidance informs prescribers and commissioners

More information

New Anticoagulants: Are we Ready to Replace Warfarin? Carole Goodine, RPh Horizon Health Network Stroke Conference 2011

New Anticoagulants: Are we Ready to Replace Warfarin? Carole Goodine, RPh Horizon Health Network Stroke Conference 2011 New Anticoagulants: Are we Ready to Replace Warfarin? Carole Goodine, RPh Horizon Health Network Stroke Conference 2011 Warfarin Decreases stroke risk by 60-70% Superior to ASA and ASA plus clopidogrel

More information

Dorset Cardiac Centre

Dorset Cardiac Centre P a g e 1 Dorset Cardiac Centre Patients with Atrial Fibrillation/Flutter undergoing DC Cardioversion or Ablation procedures- Guidelines for Novel Oral Anti-coagulants (NOACS) licensed for this use February

More information

Oral Anticoagulation in Older Persons The Next Generation

Oral Anticoagulation in Older Persons The Next Generation Oral Anticoagulation in Older Persons The Next Generation Luis Viana B.Sc. Phm., Pharm D (candidate), M.Ed., ACPR, CGP Clinical Consultant Pharmacist, Medical Pharmacies Group Limited Adjunct Clinical

More information

How To Treat Aneuricaagulation

How To Treat Aneuricaagulation Speaker Introduction Jessica Wilhoite, PharmD, BCACP Doctor of Pharmacy: Purdue University Postgraduate Residency Training: PGY1 Pharmacy Practice St. Vincent Hospital PGY2 Ambulatory Care St. Vincent

More information

Devang M. Desai, MD, FACC, FSCAI Chief of Interventional Cardiology Director of Cardiac Catheterization Lab St. Mary s Hospital and Regional Medical

Devang M. Desai, MD, FACC, FSCAI Chief of Interventional Cardiology Director of Cardiac Catheterization Lab St. Mary s Hospital and Regional Medical Devang M. Desai, MD, FACC, FSCAI Chief of Interventional Cardiology Director of Cardiac Catheterization Lab St. Mary s Hospital and Regional Medical Center A.Fib affects 2.2 million Americans. The lifetime

More information

Building a Safe Anticoagulation Program By knowing that Safety is not about numbers, Safety is about an attitude..

Building a Safe Anticoagulation Program By knowing that Safety is not about numbers, Safety is about an attitude.. Building a Safe Anticoagulation Program By knowing that Safety is not about numbers, Safety is about an attitude.. Speakers: Sue Dawson, MA, RN, CCRP Clinical Specialist-Cardiology Cam F. Campbell, M.D.

More information

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients

Prescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients Prescriber Guide 20mg Simply Protecting More Patients 15mg Simply Protecting More Patients 1 Dear Doctor, This prescriber guide was produced by Bayer Israel in cooperation with the Ministry of Health as

More information

ABOUT XARELTO CLINICAL STUDIES

ABOUT XARELTO CLINICAL STUDIES ABOUT XARELTO CLINICAL STUDIES FAST FACTS Xarelto (rivaroxaban) is a novel, oral direct Factor Xa inhibitor. On September 30, 2008, the European Commission granted marketing approval for Xarelto for the

More information

East Kent Prescribing Group

East Kent Prescribing Group East Kent Prescribing Group Rivaroxaban (Xarelto ) Safety Information Approved by the East Kent Prescribing Group. Approved by: East Kent Prescribing Group (Representing Ashford CCG, Canterbury and Coastal

More information

Uncontrolled when printed. Version 1.1. Acute Sector. Lead Author/Co-ordinator: Mr Simon Barker Consultant Orthopaedic Surgeon Julie Fraser

Uncontrolled when printed. Version 1.1. Acute Sector. Lead Author/Co-ordinator: Mr Simon Barker Consultant Orthopaedic Surgeon Julie Fraser Acute Sector NHS Grampian Staff Local Treatment Protocol For Venous Thromoboembolic Prophylaxis Using Rivaroxaban 10mg Tablets In Adult Patients Undergoing Elective Hip Or Knee Replacement Surgery. Lead

More information

Common Drug Review Pharmacoeconomic Review Report

Common Drug Review Pharmacoeconomic Review Report Common Drug Review Pharmacoeconomic Review Report August 2015 Drug rivaroxaban (Xarelto) Indication Listing request Manufacturer Treatment of venous thromboembolic events (deep vein thrombosis [DVT], pulmonary

More information

1/7/2012. Objectives. Epidemiology of Atrial Fibrillation(AF) Stroke in AF. Stroke Risk Stratification in AF

1/7/2012. Objectives. Epidemiology of Atrial Fibrillation(AF) Stroke in AF. Stroke Risk Stratification in AF Objectives Atrial Fibrillation and Prevention of Thrombotic Complications: Therapeutic Update Andrea C. Flores Pharm.D Pharmacy Resident at the Miami VA Healthcare System Review the epidemiology, pathophysiology

More information

Investor News. Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint. Not intended for U.S.

Investor News. Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint. Not intended for U.S. Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint

More information

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention

Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban

More information

NWMIC Medicines FAQ. New oral anticoagulants (NOACs) and management of dental patients - Dabigatran, rivaroxaban and apixaban.

NWMIC Medicines FAQ. New oral anticoagulants (NOACs) and management of dental patients - Dabigatran, rivaroxaban and apixaban. NWMIC Medicines FAQ New oral anticoagulants (NOACs) and management of dental patients - Date prepared: May 2013, updated November 2013 Summary In primary care; Consider liaising with the local hospital

More information

22-Oct-14. Oral Anticoagulation Which Drug for Which Patient in the era of New Oral Anti-coagulants. Atrial Fibrillation. AF as an embolic risk factor

22-Oct-14. Oral Anticoagulation Which Drug for Which Patient in the era of New Oral Anti-coagulants. Atrial Fibrillation. AF as an embolic risk factor Oral Anticoagulation Which Drug for Which Patient in the era of New Oral Anti-coagulants Dr Scott McKenzie BSc MBBS FRACP FCSANZ Cardiologist, Vascular Physician, Telehealth Specialist, Advanced Heart

More information

Comparison between New Oral Anticoagulants and Warfarin

Comparison between New Oral Anticoagulants and Warfarin Comparison between New Oral Anticoagulants and Warfarin Warfarin was the mainstay of oral anticoagulant therapy until the recent discovery of more precise targets for therapy. In recent years, several

More information

Adherence to NOACs. Disclosure. Patricia van den Bemt EAHP Hamburg 2015

Adherence to NOACs. Disclosure. Patricia van den Bemt EAHP Hamburg 2015 Adherence to NOACs Patricia van den Bemt EAHP Hamburg 2015 Disclosure Unrestricted research grants from Glaxo-SmithKline Boehringer Ingelheim Daiichi Sankyo Bayer Pfizer For research on medication safety

More information

DOACs. What s in a name? or TSOACs. Blood Clot. Darra Cover, Pharm D. Clot Formation DOACs work here. Direct Oral AntiCoagulant

DOACs. What s in a name? or TSOACs. Blood Clot. Darra Cover, Pharm D. Clot Formation DOACs work here. Direct Oral AntiCoagulant DOACs NOACs or TSOACs Generic Name DOACs Brand Name Mechanism of Action Direct Xa Inhibitor Direct Thrombin Inhibitor Dabigatran Pradaxa X Rivaroxaban Xarelto X Darra Cover, Pharm D Apixaban Eliquis X

More information

How To Get A Generic Drug From A Pharmacy Benefit Manager

How To Get A Generic Drug From A Pharmacy Benefit Manager Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 10 March 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 10 March 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 10 March 2010 ARIXTRA 1.5 mg/0.3 ml, solution for injection in pre-filled syringe Box of 2 (CIP: 363 500-6) Box of

More information

How To Compare The New Oral Anticoagulants

How To Compare The New Oral Anticoagulants Disclosures The New Oral Anticoagulants: Are they better than Warfarin? Alan P. Agins, Ph.D. does not have any actual or potential conflicts of interest in relation to this CE activity. Alan Agins, Ph.D.

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #902 March 6, 2015 NB Drug Plans Formulary Update This update to the New Brunswick Drug Plans Formulary is effective March 6, 2015. Included in this bulletin: Regular Benefit Additions Special

More information

UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient

UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient Guidelines for Anticoagulation Initiation and Management Y2014 UHS CLINICAL CARE COLLABORATION: Outpatient & Inpatient Topic Page Number MEDICATION FLOW AND PATIENT FLOW... 2 AND 3 PARENTERAL ANTICOAGULANTS...

More information

Novel Anticoagulation Agents DISCLOSURES. Objectives ATRIAL FIBRILLATION TRIALS. NOAC Comparison 6/12/2015

Novel Anticoagulation Agents DISCLOSURES. Objectives ATRIAL FIBRILLATION TRIALS. NOAC Comparison 6/12/2015 Novel Anticoagulation Agents DISCLOSURES James W. Haynes, MD Department of Family Medicine Univ of TN Health Science Center (Chattanooga) Objectives Understand mechanism of action behind the NOAC agents

More information

3/25/14. To Clot or Not What s New In Anticoagulation? Clotting Cascade. Anticoagulant drug targets. Anita Ralstin, MS CNS CNP. Heparin.

3/25/14. To Clot or Not What s New In Anticoagulation? Clotting Cascade. Anticoagulant drug targets. Anita Ralstin, MS CNS CNP. Heparin. To Clot or Not What s New In Anticoagulation? Anita Ralstin, MS CNS CNP 1 Clotting Cascade 2 Anticoagulant drug targets Heparin XI VIII IX V X VII LMWH II Warfarin Fibrin clot 1 Who Needs Anticoagulation

More information

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients

More information

All Wales Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment in People with Atrial Fibrillation

All Wales Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment in People with Atrial Fibrillation All Wales Risk/Benefit Assessment Tool for Oral Anticoagulant Treatment in People with Atrial Fibrillation October 2013 This report has been prepared by a multiprofessional collaborative group, with support

More information

New Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer s Xarelto in Patients with Non-Valvular Atrial Fibrillation

New Real-World Evidence Reaffirms Low Major Bleeding Rates for Bayer s Xarelto in Patients with Non-Valvular Atrial Fibrillation Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Late-Breaking Science at ESC Congress 2015: New Real-World Evidence Reaffirms

More information

I. UNIFORM FORMULARY REVIEW PROCESS

I. UNIFORM FORMULARY REVIEW PROCESS DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code 1074g, as implemented

More information

Optimizing Anticoagulation Selection for Your Patient. C. Andrew Brian MD, FACC NCVH 2015

Optimizing Anticoagulation Selection for Your Patient. C. Andrew Brian MD, FACC NCVH 2015 Optimizing Anticoagulation Selection for Your Patient C. Andrew Brian MD, FACC NCVH 2015 Who Needs to Be Anticoagulated and What is the Patient s Risk? 1. Atrial Fibrillation ( nonvalvular ) 2. What regimen

More information

Oral Anticoagulants: What s New?

Oral Anticoagulants: What s New? Oral Anticoagulants: What s New? Sallie Young, Pharm.D., BCPS (AQ-Cardiology) Clinical Pharmacy Specialist, Cardiology Penn State Hershey Medical Center syoung1@hmc.psu.edu August 2012 Oral Anticoagulant

More information

The speakers have attested that their presentation will be free of all commercial bias toward a specific company and its products.

The speakers have attested that their presentation will be free of all commercial bias toward a specific company and its products. Update on New Anticoagulants (Apixaban, Dabigatran and Rivaroxaban) Patient Safety Daniel B. DiCola, MD and Paul Ament,, Pharm.D Excela Heath, Latrobe, PA Disclosures: Paul Ament discloses that he receives

More information